MONIQUE COLBERT: Open Payments
NPI 1093044471 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 24 payments from 9 companies in 2025. Trend: 2023 $613 · 2024 $386 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 12 | $361 |
| Edwards Lifesciences Corporation | 1 | $143 |
| PFIZER INC. | 4 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $67 |
| BridgeBio Pharma, Inc. | 2 | $49 |
| ABIOMED | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Novo Nordisk Inc | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
Products named: CARDIOMEMS, SAPIEN 3 Ultra RESILIA, VYNDAQEL, Kerendia, Attruby, LEQVIO, 2ND GEN CENTRIMAG PRIMARY CONSOLE, Wegovy.
Industry payments across IL — which companies pay providers there.
